Table 3.
Evaluation of GRADE pro-GDT
Certainty assessment | № of patients | Effect | Certainty | Importance | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
№ of studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | Intervention | Control | Relative (95% CI) |
||
13 | Observational studies | not serious | not serious | not serious | not serious |
all plausible residual confounding would suggest spurious effect, while no effect was observed dose response gradient |
495/891 (55.6%) | 396/891 (44.4%) |
HR 1.34 (1.25 to 1.44) |
⨁⨁⨁⨁1 High |
CRITICAL |
1Certainty: ⨁⨁⨁⨁ High
The HR of OS-1.34 (1.25 to 1.44) indicated higher levels of different miRNAs expressions in TSCC patients, demonstrating great statistical significance in prognosis of TSCC patients